Posttherapeutic cerebral radionecrosis: a complication of head and neck tumor therapy
Patients with treated head and neck cancer may have focal neurologic symptoms and personality changes due to delayed cerebral radionecrosis. A history of past treatment should direct the physician to consider these lesions in the differential diagnosis. Craniotomy is the management recommended. Histopathologic changes include fibrotic response of the meninges with pleomorphic and vacuolated fibroblasts, capillary hyperplasia, reactive astrocytes, and fibrosis of the blood vessels. Amyloid is deposited in the arteriolar walls and extracellular space. Ischemic, autoimmune, or vascular mechanisms, and glial alterations have all been considered in the pathogensis of delayed cerebral radionecrosis. Some researchers have concluded that chemotherapeutic agents, such as methotrexate, may contribute to its production.
- Research Organization:
- Department of Pathology, University of Arkansas for Medical Sciences, Little Rock
- OSTI ID:
- 5500527
- Journal Information:
- South. Med. J.; (United States), Vol. 74:12
- Country of Publication:
- United States
- Language:
- English
Similar Records
Cerebral radionecrosis: incidence and risk in relation to dose, time, fractionation and volume
A pathophysiological role of TRPV1 in ischemic injury after transient focal cerebral ischemia in mice
Related Subjects
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
BRAIN
BIOLOGICAL RADIATION EFFECTS
NECROSIS
RADIOINDUCTION
RADIOTHERAPY
SIDE EFFECTS
BEHAVIOR
BLOOD VESSELS
CHEMOTHERAPY
HEAD
METHOTREXATE
NECK
NEOPLASMS
NERVOUS SYSTEM DISEASES
PATHOLOGICAL CHANGES
PATIENTS
ANTIMETABOLITES
BIOLOGICAL EFFECTS
BODY
BODY AREAS
CARDIOVASCULAR SYSTEM
CENTRAL NERVOUS SYSTEM
DISEASES
DRUGS
MEDICINE
NERVOUS SYSTEM
NUCLEAR MEDICINE
ORGANS
RADIATION EFFECTS
RADIOLOGY
THERAPY
560151* - Radiation Effects on Animals- Man
550900 - Pathology
550600 - Medicine